First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome

Q: What is the clinical evidence from this study?

Study design: Case Report. Population: Cardiorenal syndrome. Intervention: 10F Reitan catheter pump (RCP). Primary outcome: Hemodynamics and diuresis.

Q: What does this research mean for the field?

Use of the 10F percutaneous Reitan catheter pump is associated with favorable hemodynamic and diuretic effects in patients with severe cardiorenal syndrome. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Lars Christian Napp; Silvia Mariani; Arjang Ruhparwar; Bastian Schmack; Thomas  R. Keeble; Öyvind Reitan; Jasmin Sarah Hanke; Guenes Dogan; Marcus Hiß; Johann K Bauersachs; Axel Haverich; Jan Dieter Schmitto

doi:10.1097/mat.0000000000001498

June 17, 2021ASAIO JournalOpen Access

First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome

View Full Paper

Ask AI

Bookmark

Share

Key result

Reitan catheter pump is linked to improved hemodynamics and diuresis in severe cardiorenal syndrome.

Why the study?

Cardiorenal syndrome worsens outcomes in decompensated chronic heart failure and complicates recompensation by medical therapy, with mechanical circulatory support potentially improving renal function and diuretic resistance.

Does the 10F-version of the Reitan catheter pump improve hemodynamics and diuresis in patients with severe cardiorenal syndrome?

Study Design

Type

Case Report

Structured PICO

Does the 10F-version of the Reitan catheter pump improve hemodynamics and diuresis in patients with severe cardiorenal syndrome?

P

Population

First-in-man use of the 10F Reitan catheter pump for a patient with severe cardiorenal syndrome.

I

Intervention

10F-version of the Reitan catheter pump (RCP) device

O

Outcome

Hemodynamics and diuresissurrogate

The first-in-man use of the 10F Reitan catheter pump showed favorable initial effects on hemodynamics and diuresis in cardiorenal syndrome.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Hypothesis-generating for the 10F Reitan pump in cardiorenal syndrome; prospective trials needed before clinical adoption.

Abstract

Cardiorenal syndrome worsens outcome in patients with decompensated chronic heart failure, and complicates recompensation by medical therapy. Mechanical circulatory support has the potential to improve renal function, and likely mitigates diuretic resistance in patients with severe cardiorenal syndrome. The Reitan catheter pump (RCP) is a novel temporary percutaneous circulatory support system for reducing cardiac afterload and increasing renal preload. Here, we report on the first-in-man use of the 10F-version of the RCP device, which was associated with favorable effects on hemodynamics and diuresis. Further investigation to evaluate safety and efficacy of this promising approach is warranted.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Napp et al. (2021) conducted a case report in Cardiorenal syndrome. 10F Reitan catheter pump (RCP) was evaluated on Hemodynamics and diuresis. First-in-man use of the 10F Reitan catheter pump for severe cardiorenal syndrome was associated with favorable effects on hemodynamics and diuresis.

synapsesocial.com/papers/6ab9b82a10dc75cd990d2f1f https://doi.org/10.1097/mat.0000000000001498

View Full Paper

Ask AI

Bookmark

Share

First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome

Study Design

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome

Study Design

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading